Fig. 8: Circulating MIR1307 predicts benefit from FOLFIRINOX. | Nature Communications

Fig. 8: Circulating MIR1307 predicts benefit from FOLFIRINOX.

From: Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage

Fig. 8

Plasma was collected from advanced PDAC patients undergoing FOLFIRINOX chemotherapy and subjected to RNA extraction. MIR1307 expression was assessed by droplet digital PCR. Cohort was split according to median MIR1307 expression in low and high MIR1307. Kaplan−Meier curve for correlation with overall survival (OS) is shown.

Back to article page